Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colleen M Pike

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
The Journal of Infectious Diseases|December 16, 2020
Mechanisms of Colonization Resistance Against Clostridioides difficileColleen M Pike, Casey M Theriot
Infection and Immunity|July 21, 2022
Tauroursodeoxycholic Acid Inhibits Clostridioides difficile Toxin-Induced ApoptosisColleen M Pike, John Tam, Roman A Melnyk, et al.
Journal of Bacteriology|September 11, 2023
The microbial-derived bile acid lithocholate and its epimers inhibit <i>Clostridioides difficile</i> growth and pathogenicity while sparing members of the gut microbiotaSamantha C Kisthardt, Rajani Thanissery, Colleen M Pike, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2023
The microbial derived bile acid lithocholate and its epimers inhibit <i>Clostridioides difficile</i> growth and pathogenicity while sparing members of the gut microbiotaSamantha C Kisthardt, Rajani Thanissery, Colleen M Pike, et al.
The Journal of Biological Chemistry|February 9, 2019
The <i>Legionella</i> effector RavD binds phosphatidylinositol-3-phosphate and helps suppress endolysosomal maturation of the <i>Legionella</i>-containing vacuoleColleen M Pike, Rebecca Boyer-Andersen, Lisa N Kinch, et al.
Regulatory Toxicology and Pharmacology : RTP|April 12, 2026
Revisiting ICH S7A After 25 Years: Outcomes of a Multi-Stakeholder Workshop and Strategic Pillars for Modernizing Safety PharmacologyJean-Pierre Valentin, Sonja Beken, Yasunari Kanda, et al.
Frontiers in Physiology|May 13, 2026
25 years of applying the 3Rs principles in safety pharmacology: success stories and future perspectivesKatayoun Derakhchan, Kimberly Rockley, Matthias Gossmann, et al.
Infection and Immunity|June 30, 2025
<i>Clostridioides difficile</i> toxins alter host metabolic pathway and bile acid homeostasis gene expression in colonic epitheliumStephanie A Thomas, Colleen M Pike, Cypress E Perkins, et al.
NAM Journal|June 29, 2026
Transitional initiatives for advancing the phasing out of the use of animals for drug and chemical safety testing: The IHI VICT3R project for reducing the use of animals by implementing virtual control groupsFerran Sanz, Julia Matyjasiak, Javier Orihuel, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|March 14, 2025
High-throughput assay for predicting diarrhea risk using a 2D human intestinal stem cell-derived modelColleen M Pike, James A Levi, Lauren A Boone, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
The Journal of Infectious Diseases|December 16, 2020
Mechanisms of Colonization Resistance Against Clostridioides difficileColleen M Pike, Casey M Theriot
Infection and Immunity|July 21, 2022
Tauroursodeoxycholic Acid Inhibits Clostridioides difficile Toxin-Induced ApoptosisColleen M Pike, John Tam, Roman A Melnyk, et al.
Journal of Bacteriology|September 11, 2023
The microbial-derived bile acid lithocholate and its epimers inhibit <i>Clostridioides difficile</i> growth and pathogenicity while sparing members of the gut microbiotaSamantha C Kisthardt, Rajani Thanissery, Colleen M Pike, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2023
The microbial derived bile acid lithocholate and its epimers inhibit <i>Clostridioides difficile</i> growth and pathogenicity while sparing members of the gut microbiotaSamantha C Kisthardt, Rajani Thanissery, Colleen M Pike, et al.
The Journal of Biological Chemistry|February 9, 2019
The <i>Legionella</i> effector RavD binds phosphatidylinositol-3-phosphate and helps suppress endolysosomal maturation of the <i>Legionella</i>-containing vacuoleColleen M Pike, Rebecca Boyer-Andersen, Lisa N Kinch, et al.
Regulatory Toxicology and Pharmacology : RTP|April 12, 2026
Revisiting ICH S7A After 25 Years: Outcomes of a Multi-Stakeholder Workshop and Strategic Pillars for Modernizing Safety PharmacologyJean-Pierre Valentin, Sonja Beken, Yasunari Kanda, et al.
Frontiers in Physiology|May 13, 2026
25 years of applying the 3Rs principles in safety pharmacology: success stories and future perspectivesKatayoun Derakhchan, Kimberly Rockley, Matthias Gossmann, et al.
Infection and Immunity|June 30, 2025
<i>Clostridioides difficile</i> toxins alter host metabolic pathway and bile acid homeostasis gene expression in colonic epitheliumStephanie A Thomas, Colleen M Pike, Cypress E Perkins, et al.
NAM Journal|June 29, 2026
Transitional initiatives for advancing the phasing out of the use of animals for drug and chemical safety testing: The IHI VICT3R project for reducing the use of animals by implementing virtual control groupsFerran Sanz, Julia Matyjasiak, Javier Orihuel, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|March 14, 2025
High-throughput assay for predicting diarrhea risk using a 2D human intestinal stem cell-derived modelColleen M Pike, James A Levi, Lauren A Boone, et al.
Pageof 2